Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC47H56N10O11 |
InChIKeyLUHCYAOYQIFNRN-UHFFFAOYSA-N |
CAS Registry2361493-16-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 29 Mar 2019 | |
Acute Myeloid Leukemia | Preclinical | Austria | 01 Feb 2019 |